Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada, +203

The Lancet Oncology

Lymphoid NeoplasiaEnd-of-induction Pet ResponseMedicinePrognostic ValueFollicular Lymphoma +5

Hepatitis B virus carriers in the treatment of malignant lymphoma: An epidemiological study in Japan

Kyoya Kumagai, Toshiyuki Takagi, Shinobu Nakamura, +8

Annals of Oncology

Hepatitis DLymphoid NeoplasiaHepatologyViral HepatitisHepatitis B +7

A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma

Yasuhito Terui, Shinya Rai, Koji Izutsu, +18

Cancer Science

Bacillus cereus Brain Abscesses Occurring in a Severely Neutropenic Patient: Successful Treatment with Antimicrobial Agents, Granulocyte Colony-Stimulating Factor and Surgical Drainage.

Chikara Sakai, Toshihiko Iuchi, Akihiro Ishii, +2

Internal Medicine

Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation

Hideki Tsujimura, Toshiko Miyaki, Shuhei Yamada, +7

International Journal of Hematology

Surgical OncologyMalignant DiseaseMedicinePathologyDose-escalated Chop +6

Combination chemotherapy with irinotecan and adriamycin for refractory and relapsed non-Hodgkin's lymphoma

T. Saotome, Toshiyuki Takagi, Chikara Sakai, +2

Annals of Oncology

Lymphoid NeoplasiaCombination ChemotherapyMedicinePathologyAnti-cancer Agent +5

Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial

Takashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, +101

The Lancet Haematology

Jcog0203 Trial10-Year Follow-up AnalysisLymphoid NeoplasiaOncologyAdvanced Follicular Lymphoma +3

Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma

Mikiko Ise, Keiko Matsubayashi, Hideki Tsujimura, +1

Clinical Lymphoma Myeloma & Leukemia

Hematological MalignancyMedicineImmunologyImmunotherapyOncology +2

R‐High‐<scp>CHOP</scp>/<scp>CHASER</scp>/<scp>LEED</scp> with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY

Michinori Ogura, Kazuhito Yamamoto, Yasuo Morishima, +30

Cancer Science

Cell TherapyImmunologyPathologyImmunotherapyHematological Malignancy +16

Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing’s sarcoma family of tumors

Shintaro Iwata, Tsukasa Yonemoto, Takeshi Ishii, +5

International Journal of Clinical Oncology

Surgical OncologyRadiation TherapyMedicineCancer ManagementHigh-dose Chemotherapy +6